Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one
MDE20250040A1Undetermined Publication Date: 2025-01-31CARDURION PHARMA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20250040T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-01-04
- Filing Date
- 2019-05-23
- Publication Date
- 2025-01-31
Need to check novelty before this filing date? Find Prior Art
No text content released.